Affordable Access

deepdyve-link
Publisher Website

Switching to lanthanum carbonate monotherapy provides effective phosphate control with a low tablet burden.

Authors
  • Hutchison, Alastair J1
  • Laville, Maurice
  • 1 Manchester Institute of Nephrology and Transplantation, Manchester Royal Infirmary, Manchester, UK. [email protected]
Type
Published Article
Journal
Nephrology Dialysis Transplantation
Publisher
Oxford University Press
Publication Date
November 2008
Volume
23
Issue
11
Pages
3677–3684
Identifiers
DOI: 10.1093/ndt/gfn310
PMID: 18577536
Source
Medline
License
Unknown

Abstract

These findings suggest that lanthanum carbonate monotherapy offers effective control of serum phosphate and, due to a low tablet burden, may help to simplify the management of hyperphosphataemia in patients with CKD Stage 5.

Report this publication

Statistics

Seen <100 times